PMGC Holdings Inc. (ELAB)
NASDAQ: ELAB · Real-Time Price · USD
1.920
-0.020 (-1.03%)
At close: Nov 4, 2026, 4:00 PM EST
1.880
-0.040 (-2.08%)
After-hours: Nov 4, 2026, 7:46 PM EST
PMGC Holdings Revenue
PMGC Holdings had revenue of $1.31M in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $2.58M. In the year 2025, PMGC Holdings had annual revenue of $590.08K. That makes PMGC Holdings the 41,856th largest company in the world by revenue and 5,655th in the United States.
Revenue (ttm)
$2.58M
Revenue Growth
n/a
P/S Ratio
0.62
Revenue / Employee
$75,844
Employees
34
Market Cap
1.55M
Revenue by Segment
- IT Packaging Solutions 374.87K 63.5%
- Precision Engineering and Machining 215.21K 36.5%
Fiscal year ended Dec 31, 2025 See the full PMGC Holdings breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 590.08K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 766.28K | 765.45K | 92,557.44% |
| Dec 31, 2021 | 827.00 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Moolec Science | 7.83M |
| GeoVax Labs | 852.28K |
| Onconetix | 645.82K |
| BioRestorative Therapies | 357.87K |
| Silo Pharma | 54.08K |
ELAB News
- 27 days ago - PMGC announes DBA as NorthStrive, trademark license agreement - TheFly
- 27 days ago - PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update - GlobeNewsWire
- 4 weeks ago - PMGC announces completion of $100M SPAC IPO - TheFly
- 4 weeks ago - PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy - GlobeNewsWire
- 5 weeks ago - NorthStrive partners with Charles River to advance EL-22, EL-32 programs - TheFly
- 5 weeks ago - NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs - GlobeNewsWire
- 6 weeks ago - PMGC secures 5-year royalty stream from Elevai Skincare sale - TheFly
- 6 weeks ago - PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings - GlobeNewsWire